Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, Giovanni De Simone, Erwan Donal, Thomas Kahan, Giuseppe Mancia, Josep Redon, Roland Schmieder, Bryan Williams, Enrico Agabiti-Rosei

Research output: Contribution to journalArticlepeer-review

Abstract

Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of noninvasive imaging tests in the growing population of hypertensive patients.

Original languageEnglish
Pages (from-to)1727-1741
Number of pages15
JournalJournal of Hypertension
Volume35
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Keywords

  • arterial hypertension
  • cardiovascular risk
  • noninvasive cardiovascular imaging
  • prognosis
  • target organ damage

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension'. Together they form a unique fingerprint.

Cite this